Description

Oxaliplatin Amaxa Concentrate for Infusions 5 mg/ml. 40 ml. №1

Ingredients:

Each ml contains 5 mg of oxaliplatin.

Dosage:

The dosage is individualized based on the patient’s body surface area and health condition. It is administered intravenously over a specific period as directed by a healthcare professional.

Indications:

Oxaliplatin Amaxa is indicated for the treatment of colorectal cancer. It is used in combination with other chemotherapy medications.

Contraindications:

Do not use Oxaliplatin Amaxa if you are allergic to oxaliplatin or any of the ingredients in the product. It is not recommended for patients with pre-existing kidney or liver conditions.

Directions:

Administered by a healthcare professional through intravenous infusion. Follow the specific instructions provided by your doctor.

Scientific Evidence:

Oxaliplatin Amaxa has shown significant efficacy in the treatment of colorectal cancer. Studies have demonstrated its ability to inhibit the growth of cancer cells by interfering with DNA replication processes. Research published in the Journal of Clinical Oncology has highlighted the positive outcomes of oxaliplatin-based chemotherapy regimens in improving survival rates and reducing tumor progression in colorectal cancer patients.

Additional Information:

In clinical trials, Oxaliplatin Amaxa has been well-tolerated with manageable side effects. Common side effects may include peripheral neuropathy, nausea, and fatigue. It is essential to discuss any potential side effects and concerns with your healthcare provider before starting treatment with Oxaliplatin Amaxa.

Pharmacologically, Oxaliplatin Amaxa belongs to the class of platinum-based antineoplastic agents. It exerts its cytotoxic effects by forming DNA cross-links, leading to cell cycle arrest and apoptosis in cancer cells. This mechanism of action makes it a crucial component in the treatment of colorectal cancer.

Compared to similar drugs in its class, Oxaliplatin Amaxa has shown comparable efficacy with a more favorable side effect profile. Its use in combination regimens has become a standard of care in colorectal cancer treatment, showcasing its importance in modern oncology practices.